
| Brand | TOPONECHOICE |
|---|---|
| Manufacturer Part Number | JLC-112805 |
| Main Purpose | BRAIN STROKE DEMENTIA, ALZHEIMERS DISEASE AD, PARKINSON, DISORDERS OF CONSCIOUSNESS, STROKE, MIGRAINE, AUTISM, CHRONIC NEUROPATHIC PAIN, MOTOR DISEASE, PSYCHIATRIC DISEASE, AMYOTROPHIC LATERAL SCLEROSIS |
| Variable Frequency Modes | 11 MODES TO CHOOSE |
| Magnetic Field Frequency | 1/5/10/15/20/30/40/50HZ, 8 FIXED FREQUENCY ADJUSTABLE |
| Color | WHITE BLACK |
| Working Voltage | AC 110V-240V, 50HZ/60HZ |
| Material | ABS |
| Time | 0-95 MINUTES, EVERY 5 MINUTES ADJUSTABLE |
| Head Vibration Mde | AVAILABLE |
| Weak Level Magnetic Strength | 6MT-10MT |
| Type | STIMULATION DEVICE |
| Department | MEN, UNISEX, WOMEN |
| Unit Type | UNIT |
| Number Of Therapeutic Heads | 1 LARGE THERAPEUTIC HEAD 8 SMALL THERAPEUTIC HEAD |
| Manufacturer Warranty | 1 YEAR |
| Body Area | HEAD |
| Features | ADJUSTABLE |
| Strong Level Magnetic Strength | 11MT-19MT |
| Net Weight | 1KG/2.21 LBS |
| Country Of Origin | CHINA |
The JLC-112805 RTMS (Repetitive Transcranial Magnetic Stimulation) system from JINS Medical is a state-of-the-art neurostimulation device designed to enhance cognitive function in individuals with Parkinson's disease. This non-invasive brain stimulation system utilizes the latest in transcranial magnetic stimulation technology to deliver precise and targeted stimulation to specific areas of the brain.
The JLC-112805 RTMS system is compact and portable, making it an ideal choice for both clinical and home use. The device features an intuitive user interface, allowing for easy operation by healthcare professionals or patients under the guidance of their healthcare provider.
The system comes with a detachable figure-eight coil, which is the standard coil used for treating motor symptoms in Parkinson's disease. However, the JLC-112805 can also be used with other coil types, such as the circular coil, for the treatment of cognitive symptoms. The circular coil is particularly effective in stimulating larger areas of the brain, making it an excellent choice for cognitive enhancement.
The JLC-112805 RTMS system is FDA-cleared for the treatment of motor symptoms in Parkinson's disease and is currently under investigation for its use in enhancing cognitive function. The device offers adjustable stimulation intensities, frequencies, and durations, allowing for customized treatment plans tailored to each patient's unique needs.
The system includes built-in safety features, such as an automatic shut-off mechanism, overheat protection, and a patient safety switch, ensuring the safety and comfort of the user during therapy sessions. The device also comes with a battery pack, allowing for untethered use during treatments.
The JLC-112805 RTMS system from JINS Medical is a powerful tool in the fight against the cognitive impairments associated with Parkinson's disease. With its advanced technology, customizable treatment options, and user-friendly design, this neurostimulation device is an essential addition to any healthcare provider's treatment arsenal and a valuable resource for individuals seeking to improve their cognitive function and overall quality of life.
Magnetic brain stimulation, specifically repetitive transcranial magnetic stimulation (rTMS), has emerged as a promising non-pharmacological intervention for enhancing cognitive functions in individuals with Parkinson's Disease (PD). The JLC-112805 RTMS device is one of the available options for this therapy. In this text, we will discuss the potential benefits and limitations of using the JLC-112805 RTMS for cognitive enhancement in PD.
Pros:1. Non-invasive: One of the primary advantages of the JLC-112805 RTMS device is that it is non-invasive, meaning it does not require any surgery or implantation of electrodes in the brain.
2. Portable: The device is compact, making it easier for patients to use at home or while traveling.
3. Customizable: The JLC-112805 RTMS allows for adjustable stimulation parameters, enabling healthcare professionals to tailor the treatment to individual patients' needs.
4. Fewer side effects: Compared to pharmacological interventions, rTMS has fewer side effects, making it an attractive alternative for patients who experience adverse reactions to medications.
5. Improved cognitive functions: Studies have shown that rTMS can enhance various cognitive functions, including attention, working memory, and executive functions, in individuals with PD.
Cons:1. Limited clinical evidence: While the body of evidence supporting the use of rTMS for cognitive enhancement in PD is growing, it is still not extensive. More high-quality, large-scale studies are needed to further validate its efficacy.
2. Cost: The cost of purchasing and maintaining an rTMS device like the JLC-112805 RTMS can be a significant barrier for some patients, especially those without adequate insurance coverage or financial resources.
3. Complex setup: The process of setting up and administering rTMS treatments can be time-consuming and requires a certain level of expertise. Patients may need to undergo extensive training or seek professional assistance to ensure proper use of the device.
4. Variability in response: The effectiveness of rTMS treatment can vary significantly from person to person, making it essential for healthcare professionals to closely monitor patients' progress and adjust the therapy accordingly.
Conclusion:The JLC-112805 RTMS device holds promise as a non-pharmacological intervention for enhancing cognitive functions in individuals with Parkinson's Disease. Its non-invasive, portable, and customizable nature make it an attractive alternative to traditional pharmacological treatments. However, the limited clinical evidence, cost, complex setup, and variability in response are important considerations that must be addressed before widespread adoption of this technology.
Recommendation:For individuals with PD seeking cognitive enhancement, rTMS, including the JLC-112805 RTMS device, should be considered as a potential treatment option. However, it is crucial to consult with healthcare professionals to determine if this therapy is appropriate based on individual circumstances, such as the severity of symptoms, presence of comorbidities, and insurance coverage. Additionally, further research is needed to establish the long-term safety and efficacy of rTMS for cognitive enhancement in PD.
1, trans magnetic stimulation can treat alzheimer stroke disease; 2, treat motor diseases the trans cranial magnetic brain stimulation is recommend 20-30min each time, 5 times a week, continuously for 6-8 weeks or more. Principle-trans cranial magnetic stimulation is a non-invasive form of brain that uses changing Fields to induce electrical currents in specific areas the through electromagnetic induction. Tms demonstrates diagnostic and therapeutic potential in the centurions system, can be used to treat various disease states Fields of neurology and mental health.
Multi-functions of rtms therapy trans cranial magnetic treatment has 8 fixed frequency modes: 1/5/10/15/20/30/40/50hz, adjustable; trans magnetic stimulation therapy 11 conversion modes to choose from; field strength trans cranial can be optional: strong 11mt-19mt, weak 6mt-10mt ; shock, no shock optional; time: 0-95 minutes, adjustable. Trans cranial magnetic stimulation tms treatment post traumatic stress disorder. Vegetative state or minimally conscious. Package details of tms therapy treatment safe and effective.
Principle of tms treatment trans cranial magnetic stimulation outputs specific regular alternating electromagnetic field to act on brain cells and cerebral blood vessels in order change the metabolic environment lesion area, so that enzyme activity involved metabolism is increased. Magnetic has the characteristics of light weight, small volume, applicable to people with different head circumference and comfortable wear. Default us plug. Parkinson's disease ; 3, alleviate psychiatric diseases, such as depression, anxiety; 4, relieve chronic neuropathic pain; 5, improve amyotrophic lateral sclerosis, multiple sclerosis; 6, disorders of consciousness.
Insomnia, Parkinson's disease, paralysis, brain atrophy, schizophrenia, depression, anxiety, hyperactivity disorder, neurasthenia, stroke, autism, delusions, cerebral infarction. Application of trans cranial magnetic stimulation therapy rtms treatment is a painless, non-invasive, and no side effect method.